Astellas Pharma Inc ALPMF:OTCPK

RT Quote | Exchange | USD
Last | 11/30/21 EST
15.48quote price arrow down-1.39 (-8.26%)
Volume
15,440
52 week range
13.88 - 18.00
Loading...
  • Open15.65
  • Day High15.65
  • Day Low15.48
  • Prev Close15.48
  • 52 Week High18.00
  • 52 Week High Date06/22/21
  • 52 Week Low13.88
  • 52 Week Low Date12/08/20

Key Stats

  • Market Cap30,928.03M
  • Shares Out1,852.88M
  • 10 Day Average Volume5,385.5
  • Dividend0.41
  • Dividend Yield2.63%
  • Beta-
  • YTD % Change1.34

KEY STATS

  • Open15.65
  • Day High15.65
  • Day Low15.48
  • Prev Close15.48
  • 52 Week High18.00
  • 52 Week High Date06/22/21
  • 52 Week Low13.88
  • 52 Week Low Date12/08/20
  • Market Cap30,928.03M
  • Shares Out1,852.88M
  • 10 Day Average Volume5,385.5
  • Dividend0.41
  • Dividend Yield2.63%
  • Beta-
  • YTD % Change1.34

RATIOS/PROFITABILITY

  • EPS (TTM)0.58
  • P/E (TTM)26.78
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/29/2021
  • Div Amount25.00
  • Split Date-
  • Split Factor-

Latest On Astellas Pharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Yoshihiko Hatanaka
Chairman
Kenji Yasukawa
President
Naoki Okamura
Chief Financial Officer
Address
2-5-1, Nihombashihon-cho
Chuo-ku, TKY
103-8411
Japan